Product Profile

Cetirizine + Ambroxol Syrup is a clinically established, dual-action formulation indicated for allergic respiratory conditions associated with thick mucus. As a premier WHO-GMP certified pharmaceutical manufacturer in Baddi, Saar Biotech manufactures this syrup with validated two-API quality control and precise taste-masking, ensuring reliable therapeutic performance in every 5ml dose.

Manufacturing Advantage

Why Saar Biotech for Cetirizine + Ambroxol Syrup?

Since {{ site.Params.founded }}, Saar Biotech has been a distinguished WHO-GMP certified leader in pharmaceutical manufacturing. We utilize advanced micronization and pH-stabilization protocols to deliver unmatched bioavailability for this Cetirizine + Ambroxol Syrup formulation.

DCGI Approved

Comprehensive documentation and CDSCO support for rapid market entry in India.

Fast Turnaround

30-45 days lead time for new batches with state-of-the-art logistics.

Pan-India Supply & Contract Manufacturing

Batch Lead Time 30-45 Days (Domestic)
B2B Services Contract & Third-Party
Compliance DCGI & Schedule M Standards
Medical Intelligence

Clinical Q&A for Cetirizine + Ambroxol Syrup

Technical data on bioavailability, pediatric dosing protocols, and therapeutic efficacy for healthcare professionals.

What are the clinical indications for Cetirizine + Ambroxol Syrup?

This combination syrup is indicated for the symptomatic relief of allergic respiratory conditions associated with thick mucus, including allergic rhinitis, bronchitis, and cough with mucus production. Cetirizine provides antihistamine action for sneezing, runny nose, and watery eyes, while Ambroxol acts as a mucolytic, thinning and loosening phlegm for easier expectoration.

How does this combination work?

Cetirizine is a second-generation antihistamine that competitively blocks H1 receptors, reducing histamine-mediated symptoms. Ambroxol is a mucolytic agent that breaks down mucus, making it easier to expectorate. Together, they address both the allergic trigger and the mucus-related symptoms of respiratory conditions.

What is the standard dosing protocol?

The standard adult dose is 5 to 10 ml taken two to three times daily, or as directed by a physician. For pediatric patients, dosing should be weight-based under physician supervision. The syrup should be shaken well before each use and measured with a calibrated dosing device.

What are the key contraindications and precautions?

This syrup is contraindicated in patients with known hypersensitivity to any component. Cetirizine should be used with caution in patients with renal impairment. Ambroxol should be used with caution in patients with peptic ulcer disease. Use during pregnancy and lactation should be under physician supervision.

What are the common side effects?

Common side effects may include drowsiness, dry mouth, headache, and mild gastrointestinal discomfort. Most of these side effects are mild and transient. Patients should be advised to avoid alcohol and activities requiring alertness if sedation occurs.
Manufacturing Support

B2B Manufacturing Guide for Cetirizine + Ambroxol Syrup

Detailed insights on MOQs, lead times, and regulatory support for contractmanufacturing partners.

What pack sizes and packaging options are available for Cetirizine + Ambroxol Syrup?
Saar Biotech manufactures Cetirizine + Ambroxol Syrup in 60 ml and 100 ml bottle formats. Packaging options include: sticker label, metallic label, drip-off brand embossed carton, measuring cap, printed cap, company-logo printed PP cap, with-carton or without-carton supply.
What is the MOQ for this syrup?
Standard MOQ ranges from 5,000 to 10,000 units per SKU, depending on bottle size, label type, and carton format. This respiratory syrup has consistent demand, particularly during allergy seasons, and our automated filling lines in Baddi support both brand-entry volumes and large commercial runs.
What analytical tests are performed on every manufacturing batch?
Every batch undergoes HPLC Assay confirming Cetirizine and Ambroxol content against IP specifications. pH and viscosity testing confirms syrup stability. Microbial Limit Testing (MLT) meets IP standards. A Certificate of Analysis (COA) is issued with every B2B consignment.
Does Saar Biotech assist with brand name registration for Cetirizine + Ambroxol Syrup?
Yes. Our regulatory team supports brand name search and DCGI approval for antihistamine and mucolytic products. We also assist with Schedule H classification documentation and ensure all labelling meets DCGI requirements for combination respiratory syrups, including the mandatory overdose warnings and composition disclosure standards.
What is the turnaround time for a new Cetirizine + Ambroxol Syrup order?
A first-time third-party manufacturing order typically takes 30 to 45 working days from packaging artwork sign-off and raw material procurement. Established brands placing repeat commercial orders can expect delivery from our Baddi facility in approximately 20 to 25 working days, depending on batch size.
Call Us
WhatsApp
Email